PHARMING GRP SP. ADRS (PHG) — Defensive Interval Ratio
PHARMING GRP SP. ADRS (PHG) has a Defensive Interval Ratio of 238 days as of December 2025. Defensive assets of €75.56 Million (cash €-, short-term investments €33.80 Million, receivables €41.77 Million) cover 238 days of daily cash needs of €317.24K/day. See PHARMING GRP SP. ADRS working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
PHARMING GRP SP. ADRS Defensive Interval Ratio (2021–2025)
This chart shows how PHARMING GRP SP. ADRS's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 238 days, meaning defensive assets of €75.56 Million can fund 238 days of operations without new revenue. See PHARMING GRP SP. ADRS net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for PHARMING GRP SP. ADRS (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for PHARMING GRP SP. ADRS from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see PHG market cap overview.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 238 days | €75.56 Million | €317.24K/day | €- | €33.80 Million | ▼ -526 days |
| 2024 | 764 days | €154.48 Million | €202.20K/day | €- | €112.95 Million | ▼ -112 days |
| 2023 | 876 days | €187.09 Million | €213.61K/day | €- | €151.68 Million | ▲ +748 days |
| 2022 | 128 days | €20.96 Million | €163.56K/day | €- | €0.00 | ▼ -13 days |
| 2021 | 141 days | €18.08 Million | €128.14K/day | €- | €- | — |